(VIANEWS) – Ormat Technologies (ORA), CrossFirst Bankshares (CFB), Haemonetics Corporation (HAE) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Ormat Technologies (ORA)
25.2% sales growth and 4.05% return on equity
Ormat Technologies, Inc. engages in the geothermal and recovered energy power business in the United States, Indonesia, Kenya, Turkey, Chile, Guatemala, New Zealand, Honduras, and internationally. The company operates through three segments: Electricity, Product, and Energy Storage and Management Services. The Electricity segment develops, builds, owns, and operates geothermal, solar photovoltaic (PV), and recovered energy-based power plants; and sells electricity. The Product segment designs, manufactures, and sells equipment for geothermal, recovered energy-based electricity generation, and remote power units, such as fossil fuel powered turbo-generators and heavy duty direct-current generators. This segment also provides services relating to the engineering, procurement, construction, operation, and maintenance of geothermal, solar PV, and recovered energy-based power plants. The Product segment serves contractors; developers, owners, and operators of geothermal power plants; and owners and operators of interstate natural gas pipelines, gas processing plants, and cement plants, as well as companies in other energy-intensive industrial processes. The Energy Storage and Management Services segment offers energy storage, demand response, and energy management related services, as well as services relating to the engineering, procurement, construction, operation, and maintenance of energy storage units. Ormat Technologies, Inc. was founded in 1965 and is based in Reno, Nevada.
Earnings Per Share
As for profitability, Ormat Technologies has a trailing twelve months EPS of $1.34.
PE Ratio
Ormat Technologies has a trailing twelve months price to earnings ratio of 62.3. Meaning, the purchaser of the share is investing $62.3 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.05%.
2. CrossFirst Bankshares (CFB)
17.7% sales growth and 9.6% return on equity
CrossFirst Bankshares, Inc. operates as the bank holding company for CrossFirst Bank that provides various banking and financial services to businesses, business owners, professionals, and its personal networks. The company offers commercial real estate, construction and development, 1-4 family real estate, commercial, energy, and consumer loans. It also provides a range of deposit products consisting of noninterest-bearing demand and interest-bearing deposits, which include transaction accounts, savings accounts, money market accounts, and certificates of deposit; and personal and business checking and savings accounts, as well as negotiable order of withdrawal accounts; and brokered and reciprocal deposits. In addition, the company offers international banking services; treasury management services; automated teller machine access; and mobile banking services. Further, it holds investments in marketable securities. The company operates eight full-service banking centers located in Leawood and Wichita, Kansas; Kansas City, Missouri; Oklahoma City and Tulsa, Oklahoma; and Dallas and Frisco, Texas. CrossFirst Bankshares, Inc. was founded in 2007 and is headquartered in Leawood, Kansas.
Earnings Per Share
As for profitability, CrossFirst Bankshares has a trailing twelve months EPS of $1.2.
PE Ratio
CrossFirst Bankshares has a trailing twelve months price to earnings ratio of 8.16. Meaning, the purchaser of the share is investing $8.16 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.6%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 19.6%, now sitting on 208.85M for the twelve trailing months.
Moving Average
CrossFirst Bankshares’s worth is below its 50-day moving average of $10.72 and way below its 200-day moving average of $12.75.
3. Haemonetics Corporation (HAE)
15.1% sales growth and 14.72% return on equity
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; and Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.
Earnings Per Share
As for profitability, Haemonetics Corporation has a trailing twelve months EPS of $2.2.
PE Ratio
Haemonetics Corporation has a trailing twelve months price to earnings ratio of 38.24. Meaning, the purchaser of the share is investing $38.24 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.72%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 14.9%, now sitting on 1.17B for the twelve trailing months.
Sales Growth
Haemonetics Corporation’s sales growth is 10.7% for the current quarter and 15.1% for the next.
4. CAE Ordinary Shares (CAE)
11.1% sales growth and 4.42% return on equity
CAE Inc., together with its subsidiaries, designs, manufactures, and supplies simulation equipment and training solutions to defense and security markets, commercial airlines, business aircraft operators, helicopter operators, aircraft manufacturers, and healthcare education and service providers worldwide. The company's Civil Aviation Training Solutions segment provides training solutions for flight, cabin, maintenance, and ground personnel in commercial, business, and helicopter aviation; flight simulation training devices; and ab initio pilot training and crew sourcing services, as well as end to end digitally-enabled crew management, training operations solutions, and optimization software. Its Defence and Security segment offers training and mission support solutions for defense forces across multi-domain operations, and for government organizations responsible for public safety. The company's Healthcare segment provides integrated education and training solutions, including surgical and imaging simulations, curriculum, audiovisual and centre management platforms, and patient simulators to healthcare students and clinical professionals. It has a strategic partnership with Volocopter GmbH to develop, certify, and deploy a pilot training program for electric vertical takeoff and landing operations. The company was formerly known as CAE Industries Ltd. and changed its name to CAE Inc. in June 1993. CAE Inc. was founded in 1947 and is headquartered in Saint-Laurent, Canada.
Earnings Per Share
As for profitability, CAE Ordinary Shares has a trailing twelve months EPS of $0.43.
PE Ratio
CAE Ordinary Shares has a trailing twelve months price to earnings ratio of 52.22. Meaning, the purchaser of the share is investing $52.22 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.42%.
5. Hartford Financial Services Group (HIG)
9.8% sales growth and 12.61% return on equity
The Hartford Financial Services Group, Inc. provides insurance and financial services to individual and business customers in the United States, the United Kingdom, and internationally. Its Commercial Lines segment offers insurance coverages, including workers' compensation, property, automobile, general and professional liability, package business, umbrella, fidelity and surety, marine, livestock, and reinsurance through regional offices, branches, sales and policyholder service centers, independent retail agents and brokers, wholesale agents, and reinsurance brokers. The company's Personal Lines segment provides automobile, homeowners, and personal umbrella coverages through direct-to-consumer channel and independent agents. Its Property & Casualty Other Operations segment offers coverage for asbestos and environmental exposures. The company's Group Benefits segment provides group life, disability, and other group coverages to members of employer groups, associations, and affinity groups through direct insurance policies; reinsurance to other insurance companies; employer paid and voluntary product coverages; disability underwriting, administration, and claims processing to self-funded employer plans; and a single-company leave management solution. This segment distributes its group insurance products and services through brokers, consultants, third-party administrators, trade associations, and private exchanges. Its Hartford Funds segment offers managed mutual funds across various asset classes; and exchange-traded products through broker-dealer organizations, independent financial advisers, defined contribution plans, financial consultants, bank trust groups, and registered investment advisers, as well as investment management, distribution, and administrative services, such as product design, implementation, and oversight. The company was founded in 1810 and is headquartered in Hartford, Connecticut.
Earnings Per Share
As for profitability, Hartford Financial Services Group has a trailing twelve months EPS of $5.8.
PE Ratio
Hartford Financial Services Group has a trailing twelve months price to earnings ratio of 11.83. Meaning, the purchaser of the share is investing $11.83 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.61%.
6. Regional Management Corp. (RM)
9.1% sales growth and 10.77% return on equity
Regional Management Corp., a diversified consumer finance company, provides various installment loan products primarily to customers with limited access to consumer credit from banks, thrifts, credit card companies, and other lenders in the United States. It offers small and large installment loans; and retail loans to finance the purchase of furniture, appliances, and other retail products. The company also provides insurance products, including credit life, credit accident and health, credit property, vehicle single interest, and credit involuntary unemployment insurance; collateral protection insurance; and property insurance, as well as reinsurance products. In addition, its loans are sourced through branches, centrally managed direct mail campaigns, digital partners, and retailers, as well as its consumer website. As of February 24, 2022, the company operated through a network of approximately 350 branches in 14 states. Regional Management Corp. was incorporated in 1987 and is headquartered in Greer, South Carolina.
Earnings Per Share
As for profitability, Regional Management Corp. has a trailing twelve months EPS of $3.57.
PE Ratio
Regional Management Corp. has a trailing twelve months price to earnings ratio of 7.41. Meaning, the purchaser of the share is investing $7.41 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.77%.
7. Cooper Companies (COO)
6.4% sales growth and 5.26% return on equity
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Earnings Per Share
As for profitability, Cooper Companies has a trailing twelve months EPS of $7.56.
PE Ratio
Cooper Companies has a trailing twelve months price to earnings ratio of 48.76. Meaning, the purchaser of the share is investing $48.76 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.26%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is a negative 7.1% and positive 4.1% for the next.
Yearly Top and Bottom Value
Cooper Companies’s stock is valued at $368.61 at 01:22 EST, under its 52-week high of $395.20 and way above its 52-week low of $244.22.
Previous days news about Cooper Companies(COO)
- According to Zacks on Thursday, 25 May, "Another Medical stock, which has outperformed the sector so far this year, is The Cooper Companies (COO Quick QuoteCOO – Free Report) . ", "Investors interested in the Medical sector may want to keep a close eye on Adagene Inc. Sponsored ADR and The Cooper Companies as they attempt to continue their solid performance."
- What makes the cooper companies (coo) a new buy stock. According to Zacks on Thursday, 25 May, "The upgrade of The Cooper Companies to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.", "Fundamentally speaking, rising earnings estimates and the consequent rating upgrade for The Cooper Companies imply an improvement in the company’s underlying business. "
